Genomics and Epigenomics in the Molecular Biology of Melanoma—A Prerequisite for Biomarkers Studies

Daniela Luminita Zob, Iolanda Augustin, Lavinia Caba, Monica Cristina Panzaru, Setalia Popa, Alina Delia Popa, Laura Florea, Eusebiu Vlad Gorduza

Résultats de recherche: Contribution à un journalArticle 'review'Revue par des pairs

9 Citations (Scopus)

Résumé

Melanoma is a common and aggressive tumor originating from melanocytes. The increasing incidence of cutaneous melanoma in recent last decades highlights the need for predictive biomarkers studies. Melanoma development is a complex process, involving the interplay of genetic, epigenetic, and environmental factors. Genetic aberrations include BRAF, NRAS, NF1, MAP2K1/MAP2K2, KIT, GNAQ, GNA11, CDKN2A, TERT mutations, and translocations of kinases. Epigenetic alterations involve microRNAs, non-coding RNAs, histones modifications, and abnormal DNA methylations. Genetic aberrations and epigenetic marks are important as biomarkers for the diagnosis, prognosis, and prediction of disease recurrence, and for therapeutic targets. This review summarizes our current knowledge of the genomic and epigenetic changes in melanoma and discusses the latest scientific information.

langue originaleAnglais
Numéro d'article716
journalInternational Journal of Molecular Sciences
Volume24
Numéro de publication1
Les DOIs
étatPublié - 1 janv. 2023
Modification externeOui

Contient cette citation